Previous research demonstrated that GLC treatment reduced tumor necrosis factor (TNF)-α, interleukin (IL)-6, and NF-κB following experimental cardiac arrest (Nakayama et al., 2018). This evidence concerns the gene TNF and cardiac arrest.